Hosted on MSN

Helping an MS friend sort out disability benefits

I was having a chat recently with a friend with multiple sclerosis (MS). We first met when I chartered him as a consultant, then we became colleagues, then friends and then friends with multiple ...
MedPage Today

High Fish Consumption Tied to Less Disability Progression in Multiple Sclerosis

High fish consumption was linked with slower disability progression in MS. Benefits were seen for both lean and oily fish consumption. Protective effects were strongest with consistent fish ...
Medscape

Fish-Rich Diet May Slow Multiple Sclerosis Disability Progression

Higher consumption of oily fish such as tuna and salmon or lean fish like cod and perch is associated with a reduced risk for disability progression in patients with multiple sclerosis (MS), a new ...
UPI

Experimental drug shown to slow multiple sclerosis disability

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib, delayed ...
Science Daily

Study finds certain MS therapies may not slow disability progression

In people with primary progressive multiple sclerosis (MS), a new study has found no difference in the amount of time before disability worsened between people taking certain medications and those not ...
Medscape

Novel Agent First to Slow Disability in Nonrelapsing Secondary MS

COPENHAGEN, Denmark — A new investigational drug has become the first agent to slow disability in patients with nonrelapsing secondary progressive multiple sclerosis (nrSPMS). The Phase 3 HERCULES ...
MedPage Today

Physical Activity Tied to Lower Risk of MS Disability Outcomes

Physical activity was associated with a lower risk of disability progression in multiple sclerosis (MS), longitudinal data showed. Compared with low physical activity, the risk of confirmed disability ...
The American Journal of Managed Care

Tolebrutinib Delays Disability Progression in Nonrelapsing Secondary Progressive MS

The HERCULES study of tolebrutinib is the first and only to show reduced confirmed disability progression at 6 months in nonrelapsing secondary progressive multiple sclerosis (MS). The HERCULES ...
Medical Xpress

Early treatment significantly reduces long-term disability in children with multiple sclerosis, new study finds

New research presented today at European Committee for Treatment and Research in Multiple Sclerosis 2024 reveals that initiating monoclonal antibody therapy during childhood, rather than delaying ...
Yahoo

Helping an MS Friend Sort Out Disability Benefits

Add Yahoo as a preferred source to see more of our stories on Google. hand signing disability benefit document inside computer with speech bubbles question marks on yellow.iStock (3); Everyday Health ...
Medical Xpress

Study finds certain multiple sclerosis therapies may not slow disability progression

In people with primary progressive multiple sclerosis (MS), a new study has found no difference in the amount of time before disability worsened between people taking certain medications and those not ...